IUIS relationship with the World Health Organization

September 15, 2017

 

IUIS has long had an informal relationship with the World Health Organisation (WHO). In 2017, this relationship was formalized according to WHO guidelines. The goal of the collaboration is to advance WHO’s work on quality, safety and efficacy of medical biological products with IUIS providing relevant expert immunology knowledge. Our new relationship involves planned contributions from IUIS and its members.

Specifically, we will work together on the WHO Programme Area: access to medicines and health technologies and strengthening regulatory capacity.

 

IUIS will provide support and knowledge in determining norms and standards for biologicals, especially vaccines, and scientific input on nomenclature of immunology molecules. We also support educational activities and communication to strengthen expertise in immunology.

 

We are grateful to Ivana Knezevic, who is our WHO liaison and has helped us immensely in creating this collaboration. We look forward to some exciting outcomes in the next three years.

More News

We have a winner! 2020 Early Career Research Prize in Vaccinology R&D

May 18, 2020Vaccine Committee (VAC)

2020 Edition: Day of Immunology

April 30, 2020

Menarini Prize for Outstanding Woman Immunologist

April 29, 2020Gender Equality Committee (GEC)

Announcement of a New “Travel for Expertise” Travel Grant Program

April 23, 2020Gender Equality Committee (GEC)

Webinar on-demand: Rino Rappuoli on COVID-19 Vaccines

April 8, 2020

Webinar: COVID-19 Vaccines

April 3, 2020

The British Immunological Society launches the “Celebrate Vaccines” campaign on March 26

March 25, 2020

CALL FOR EXPERTS: IUIS-Frontiers in Immunology Webinar Series on COVID-19

March 13, 2020

Modified tuberculosis vaccine as therapy against bladder cancer

March 5, 2020